Cargando…
The Effects of the CXCR4 Antagonist, AMD3465, on Human Retinal Vascular Endothelial Cells (hRVECs) in a High Glucose Model of Diabetic Retinopathy
BACKGROUND: High blood glucose levels in diabetes result in retinal angiogenesis, which is the key feature of diabetic retinopathy. This study aimed to investigate the effects of the CXCR4 antagonist, AMD3465, on human retinal vascular endothelial cells (hRVECs) in vitro. MATERIAL/METHODS: Cell viab...
Autores principales: | Wu, Di, Jin, Li, Xu, Hongshuang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International Scientific Literature, Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6761849/ https://www.ncbi.nlm.nih.gov/pubmed/31860633 http://dx.doi.org/10.12659/MSM.917186 |
Ejemplares similares
-
The CXCR4 Antagonist AMD3465 Regulates Oncogenic Signaling and Invasiveness In Vitro and Prevents Breast Cancer Growth and Metastasis In Vivo
por: Ling, Xiaoyang, et al.
Publicado: (2013) -
ATN-161 as an Integrin α5β1 Antagonist Depresses Ocular Neovascularization by Promoting New Vascular Endothelial Cell Apoptosis
por: Sui, Ailing, et al.
Publicado: (2018) -
MicroRNA Expression Analysis in Serum of Patients with Congenital Hemochromatosis and Age-Related Macular Degeneration (AMD)
por: Szemraj, Maciej, et al.
Publicado: (2017) -
Plumbagin Restrains Hepatocellular Carcinoma Angiogenesis by Stromal Cell-Derived Factor (SDF-1)/CXCR4-CXCR7 Axis
por: Zhong, Jing, et al.
Publicado: (2019) -
Therapy-Induced Changes in CXCR4 Expression in Tumor Xenografts Can Be Monitored Noninvasively with N-[(11)C]Methyl-AMD3465 PET
por: Hartimath, SV, et al.
Publicado: (2019)